Literature DB >> 8031026

Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.

R Ben-Yaacov1, S Knoller, G A Caldwell, J M Becker, Y Koltin.   

Abstract

Candida albicans is not inhibited by a number of drugs known to affect fungal cells. The basis for this resistance in most cases is unknown but has been attributed to the general impermeability of the fungal cell envelope. A gene (BENr) formerly shown to be responsible for the resistance of C. albicans to benomyl and methotrexate was shown in the present study to confer resistance to four other inhibitory compounds: cycloheximide, benztriazoles, 4-nitroquinoline-N-oxide, and sulfometuron methyl. Analysis of the protein database revealed an apparent similarity of the C. albicans gene to membrane protein genes encoding antibiotic resistance in prokaryotes and eukaryotes and a high degree of identity to a recently cloned gene encoding cycloheximide resistance in Candida maltosa. We propose that BENr encodes a protein that operates in a fashion similar, but not identical, to that described for other multiple-drug resistance proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031026      PMCID: PMC284519          DOI: 10.1128/AAC.38.4.648

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Identification of a gene for beta-tubulin in Aspergillus nidulans.

Authors:  G Sheir-Neiss; M H Lai; N R Morris
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

Review 2.  Mode of action of clinically important antifungal drugs.

Authors:  D Kerridge
Journal:  Adv Microb Physiol       Date:  1986       Impact factor: 3.517

Review 3.  Gene amplification in cultured animal cells.

Authors:  R T Schimke
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Isolation of genes from Candida albicans by complementation in Saccharomyces cerevisiae.

Authors:  A Rosenbluh; M Mevarech; Y Koltin; J A Gorman
Journal:  Mol Gen Genet       Date:  1985

6.  Cell division cycle genes nda2 and nda3 of the fission yeast Schizosaccharomyces pombe control microtubular organization and sensitivity to anti-mitotic benzimidazole compounds.

Authors:  K Umesono; T Toda; S Hayashi; M Yanagida
Journal:  J Mol Biol       Date:  1983-08-05       Impact factor: 5.469

7.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

8.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

9.  Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae.

Authors:  J H Thomas; N F Neff; D Botstein
Journal:  Genetics       Date:  1985-12       Impact factor: 4.562

10.  Cycloheximide resistance in yeast: the gene and its protein.

Authors:  N F Käufer; H M Fried; W F Schwindinger; M Jasin; J R Warner
Journal:  Nucleic Acids Res       Date:  1983-05-25       Impact factor: 16.971

View more
  52 in total

1.  Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H+ transport.

Authors:  Ritu Pasrija; Dibyendu Banerjee; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2007-01-05

Review 2.  Multidrug resistance in fungi.

Authors:  Kailash Gulshan; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2007-09-14

3.  Reduced virulence of Candida albicans mutants affected in multidrug resistance.

Authors:  J M Becker; L K Henry; W Jiang; Y Koltin
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 4.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 5.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

Review 6.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

7.  In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

Authors:  A L Fachin; C M Maffei; N M Martinez-Rossi
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

8.  SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.

Authors:  Bernardo Ramírez-Zavala; Selene Mogavero; Eva Schöller; Christoph Sasse; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

9.  Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene GCS1, is required for hyphal growth and drug resistance.

Authors:  Thomas Lettner; Ute Zeidler; Mario Gimona; Michael Hauser; Michael Breitenbach; Arnold Bito
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

10.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.